GVR Report cover Brain Imaging Devices Market (2026 - 2033)Report

Brain Imaging Devices Market (2026 - 2033)

Size, Share & Trends Analysis Report By Product (Devices, Accessories), By Application (Stroke, Brain Tumor, TBI, Epilepsy, Sleep Apnea, Headache, Structural Anomalies), By Modality (Fixed, Portable, Wearable), By End-use, By Region, And Segment Forecasts

Market Size, 2025

$6.1B

Market Estimate, 2026

$6.6B

Market Forecast, 2033

$11.4B

CAGR, 2026–2033

8.2%

Brain Imaging Devices Market Summary

The global brain imaging devices market size was valued at USD 6.1 billion in 2025 and is projected to grow from USD 6.6 billion in 2026 to USD 11.4 billion in 2033, at a CAGR of 8.2% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 39.0% in 2025. Technological advancements in brain imaging, such as improved resolution, functional imaging techniques, and non-invasive methods, are significantly enhancing diagnostic capabilities.

Key Market Trends & Insights

  • By product: The devices segment held the largest revenue share of 81.5% in 2025.
  • By application: The brain tumor segment held the largest revenue share in 2025.
  • By modality: The fixed segment dominated the market with the largest share in 2025.
  • By end-use, the hospital segment held the largest revenue share in 2025.

Regional Highlights

  • Largest regional market: North America (Over 39.0% revenue share, 2025)
  • Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)

Market Size & Forecast

  • Market size in 2025: USD 6.1 Billion
  • Estimated market size in 2026: USD 6.6 Billion
  • Projected market size by 2033: USD 11.4 Billion
  • CAGR (2026-2033): 8.2%
Ask a question about the brain imaging devices market
Try asking
✓Every figure cited from GVR research Prefer the report? Download free sample →


The increasing prevalence of brain and neurological disorders, including Alzheimer's, Parkinson's disease, and stroke, is further fueling the demand for these advanced imaging solutions. Healthcare providers and researchers are relying more on sophisticated brain imaging devices to detect, monitor, and treat these conditions effectively.

Brain imaging devices market size and growth forecast (2023-2033)Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, icon Download Free Sample Report

The market growth is anticipated to be driven by the availability of various brain imaging technologies, including magnetic resonance imaging (MRI), computed tomography (CT), Magnetoencephalography (MEG), Electroencephalography (EEG), and PET scanners, which offer applications for both functional and structural imaging. In addition, technological advancements, such as the incorporation of AI, the development of wearable brain imaging devices, and other innovations, are expected to further contribute to this growth. For instance, Hyperfine, Inc. announced the FDA approval of the world's first portable magnetic resonance brain imaging system -the Swoop system in January 2024. They introduced the eighth generation of its AI-enhanced Swoop system software. This latest update significantly boosts the image quality produced by the Swoop system and offers major enhancements in ease of use, including a real-time assistance feature to improve patient positioning accuracy and a streamlined process for image uploads.

Analyst Perspective

The market is witnessing steady expansion, supported by the rising global burden of neurological disorders such as stroke, Alzheimer’s disease, epilepsy, brain tumors, and Parkinson’s disease, which is significantly increasing demand for accurate and early diagnostic imaging solutions. Technological advancements in MRI, CT, PET, EEG, and MEG systems, particularly the integration of AI-based image reconstruction, portable and ultra-low-field MRI systems, and improved functional imaging techniques, are enhancing diagnostic precision, workflow efficiency, and accessibility in both developed and emerging healthcare systems. North America continues to dominate the market due to its advanced healthcare infrastructure, strong presence of leading imaging device manufacturers, high adoption of innovative technologies, and favorable reimbursement frameworks that support widespread utilization of advanced neuroimaging solutions. Meanwhile, increasing government initiatives focused on neurological disease awareness and early diagnosis, along with growing investments in diagnostic imaging centers and hospital infrastructure, are further accelerating global market penetration.

Product Insights

The devices segment dominated the market, accounting for approximately 81.5% of revenue in 2025, driven by rising demand for advanced diagnostic tools. This segment encompasses devices used for brain imaging and functional scanning, including CT, MRI, MEG, EEG, PET, and other equipment, such as sleep-monitoring and electromyography devices. Among these, MRI held a significant market share in 2025, primarily due to its capabilities in functional magnetic resonance imaging (fMRI), which detects changes in blood flow and oxygen levels associated with brain activity. This technique utilizes the scanner’s magnetic field to manipulate the magnetic nuclei of hydrogen atoms, enabling their measurement and conversion into detailed images.

Furthermore, the electroencephalography (EEG) devices market is expected to exhibit the fastest CAGR among the device segments over the forecast period. EEG devices record electrical activity in the brain and assist in diagnosing conditions such as epilepsy and sleep disorders. They are also increasingly used in neurofeedback therapies and brain-computer interfaces. Technological advancements in EEG devices are propelling the segment’s growth. Modern EEG systems are becoming more advanced, offering higher resolution, improved portability, and user-friendly interfaces. The integration of artificial intelligence (AI) and machine learning (ML) into EEG analysis is transforming the landscape of neurological research and clinical diagnostics.

AI algorithms can process and interpret complex EEG data more quickly and accurately than traditional methods. This capability enhances the diagnostic process for conditions such as epilepsy, enabling faster and more precise seizure detection. Moreover, AI-driven EEG analysis opens new possibilities for personalized medicine, where treatments can be tailored to an individual’s unique brain activity patterns. For instance, in April 2024, a team from the Creativity Research Lab at Drexel University developed an artificial intelligence method capable of accurately estimating a person's brain age using EEG scans. This innovation could support early and frequent screenings for neurodegenerative conditions. The findings were published in the journal Frontiers in Neuroergonomics.

“Brain MRIs are expensive, and until now, brain-age estimation has only been done in neuroscience research laboratories. But my colleagues and I have developed a machine-learning technology to estimate a person's brain age using a low-cost EEG system. It can be used as a relatively inexpensive way to screen large numbers of people for vulnerability to age-related conditions. And because of its low cost, a person can be screened at regular intervals to monitor changes over time. This can help assess the effectiveness of medications and other interventions. Even healthy individuals could use this technique to evaluate the impact of lifestyle changes as part of an overall strategy for optimizing brain performance.”

- John Kounios, Ph.D., Professor, Drexel University College of Arts and Sciences, and Director of the Creativity Research Lab

The accessories segment is anticipated to be the fastest-growing, with a high CAGR over the forecast period, driven by advancements in imaging modalities, rising demand for precise brain scans, and greater awareness of neurological disorders requiring comprehensive diagnosis and monitoring. Essential components within this segment, such as electrodes, sensors, MRI machine coils, cables, batteries, and contrast agents, are enhancing image clarity and are expected to complement primary imaging devices. Ongoing advancements and innovations in these accessories are significant factors in improving the overall effectiveness and efficiency of brain imaging techniques, thereby driving the growth of this segment.

Application Insights

The brain tumor segment accounted for the largest revenue share in 2025, driven by the increasing prevalence of the condition. As brain tumor cases become more common, there is a growing demand for advanced imaging techniques to detect and monitor these tumors accurately. Consequently, the market for brain imaging technologies, particularly those specialized in tumor detection, is expected to experience significant growth.

The epilepsy segment is expected to grow at the fastest CAGR during the forecast period. Advances in imaging technologies have improved the ability to identify and diagnose epilepsy-related anomalies in the brain, driving demand for specialized imaging equipment. Furthermore, increasing awareness of epilepsy and its neurological implications has led to a greater focus on early detection and intervention, contributing to market expansion. In addition, ongoing research and development efforts to improve imaging modalities for epilepsy diagnosis and monitoring are fostering market innovation and creating broader opportunities for industry participants.

Modality Insights

The fixed segment dominated the market, accounting for the largest revenue share in 2025. Fixed imaging devices provide high-resolution images of the brain, facilitating precise diagnosis and treatment planning for various brain disorders. Commonly available in imaging centers, hospitals, and diagnostic facilities, these devices provide access for both healthcare professionals and patients seeking accurate neurological assessments. Moreover, they often integrate advanced features such as multi-modal imaging and specialized software, which enhance diagnostic accuracy and adaptability. In addition, the rising incidence of neurological conditions has fueled demand for effective brain imaging solutions, thereby contributing to growth in the fixed imaging devices segment.

The portable segment is anticipated to be the fastest-growing segment from 2026 to 2033. These devices offer several advantages over traditional fixed systems due to their mobility and flexibility, enabling healthcare professionals to perform brain imaging procedures conveniently in a variety of settings, including clinics, ambulances, and remote locations. This portability enhances access to imaging services, especially in regions with limited healthcare infrastructure or during emergencies when rapid diagnosis is essential. Key drivers of growth in this segment include the rising prevalence of neurological disorders, the need for early, accessible diagnosis, advances in wearable technologies, and growing interest in brain-computer interfaces (BCIs). In addition, the demand for real-time monitoring of brain health in everyday environments is significantly accelerating market expansion. Emerging players are actively involved in the research and development of new and innovative brain imaging devices to remain competitive.

End-use Insights

The hospital segment held the largest revenue share in 2025. Hospitals play a crucial role in diagnosing and treating neurological disorders, often requiring advanced brain imaging technologies. These facilities typically have financial resources to invest in cutting-edge equipment, enabling them to deliver comprehensive diagnostic services to patients. In addition, hospitals employ multidisciplinary teams of specialists, such as neurologists, neurosurgeons, and radiologists, who collaborate to ensure accurate diagnoses and effective treatment strategies. The growing global prevalence of neurological conditions is expected to further drive demand for brain imaging devices in hospitals, underscoring the importance of precise, timely diagnostics in managing these disorders.

The diagnostic imaging centers segment is expected to grow at the fastest CAGR during the forecast period. With increasing awareness of the importance of early diagnosis and treatment for brain-related conditions, there is a growing reliance on these centers for their specialized equipment and expertise. Moreover, diagnostic centers are quick to adopt the latest advancements in imaging technology to maintain high diagnostic accuracy and efficiency. For instance, in March 2024, Fujifilm India announced the installation of its innovative open MRI machine, APERTO Lucent, at the Vijaya Diagnostic Center in Hyderabad. The convenience and accessibility offered by these centers are also contributing to their rising adoption among patients.

Regional Insights

The North American brain imaging devices market dominated the global market, accounting for over 39.0% of global revenue in 2025. Technological advancements in brain imaging devices, such as high-resolution MRI, PET scans, and functional MRI, significantly enhance diagnostic capabilities, fueling market growth in North America. For instance, in November 2025, GE HealthCare expanded its SIGNA MRI portfolio with next-generation high-field MRI systems featuring advanced reconstruction and workflow automation capabilities to improve neuroimaging precision and reduce scan time. The enhancement supports more efficient detection of neurological disorders such as stroke, brain tumors, and neurodegenerative diseases, reinforcing the growing clinical adoption of high-resolution MRI systems across advanced healthcare facilities. These innovations are improving the accuracy and speed of detecting neurological disorders. Furthermore, the rising prevalence of conditions, particularly Alzheimer’s, Parkinson’s, and stroke, is driving increased demand for early and accurate diagnostic tools. Healthcare providers are increasingly adopting these advanced imaging solutions to support improved treatment planning and monitoring, further boosting market growth in the region.

Factors such as advanced healthcare infrastructure, substantial medical research, and technology investments fuel market growth. This infrastructure supports the adoption of cutting-edge brain imaging technologies. In addition, North America is home to numerous medical device manufacturers and neuroscience research institutions. These organizations drive innovation and advancements in brain imaging devices, contributing to the market expansion in this region.

Brain Imaging Devices Market Trends, by Region, 2026 - 2033

To learn more about this report, icon Download Free Sample Report

U.S. Brain Imaging Devices Market Trends

The brain imaging devices market in the U.S. held the largest share of the regional market in 2025, owing to the growing focus on early detection of neurological disorders. Early diagnosis enables more effective treatment and better patient outcomes, prompting increased adoption of advanced imaging technologies. Moreover, the trend toward developing portable and compact brain imaging devices is enhancing accessibility and convenience, making it easier to perform diagnostics in various settings, including remote areas and point-of-care locations. These innovations are improving healthcare delivery and fueling the overall market growth in the U.S.

The growth can also be attributed to major market players in this country, such as GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips N.V. Furthermore, various initiatives undertaken by key market players are expected to contribute to market growth. For instance, in January 2024, Siemens Healthcare Private Limited announced the FDA approval of the MAGNETOM Cima—X 3 Tesla (3T) magnetic resonance imaging scanner.

Asia Pacific Brain Imaging Devices Market Trends

The brain imaging devices market in the Asia Pacific is expected to be the fastest-growing region, with a high CAGR over the forecast period, propelled by rising healthcare investments and an aging population. Increased funding for healthcare infrastructure enhances access to advanced diagnostic technologies. At the same time, the aging population’s susceptibility to neurological conditions such as Alzheimer’s and stroke boosts the demand for accurate imaging solutions. These demographic shifts, coupled with innovations in medical technology, create a favorable environment for the market's growth, fostering the development of more advanced and accessible brain imaging devices across the region.

The increasing prevalence of brain-related disorders and ailments in countries across the Asia-Pacific region is driving demand for advanced diagnostic technologies. Conditions such as Alzheimer's disease, Parkinson's disease, and stroke are becoming more prevalent due to factors such as aging populations, lifestyle changes, and improved disease awareness. Thus, there is a growing need for accurate and timely diagnosis, which brain imaging devices can provide.

Japan brain imaging devices market is projected to grow at the fastest CAGR in the regional market during the forecast period, driven by the country's focus on technological advancement and the widespread adoption of advanced solutions. For instance, in November 2023, RapidAI, a healthcare technology firm specializing in imaging analysis software, announced its achievement of Class III Shonin clearance in Japan. Along with this regulatory milestone, RapidAI introduced a hybrid technology platform named Rapid Edge Cloud and a non-contrast CT solution for stroke identification within the Japanese market.

Europe Brain Imaging Devices Market Trends

The brain imaging devices market in Europe is anticipated to witness significant expansion over the forecast period. Integrating AI and machine learning technologies into brain imaging devices is set to drive the regional market by enhancing diagnostic accuracy, efficiency, and treatment planning. These technologies enable more precise identification of neurological disorders, such as brain tumors, Alzheimer's, and stroke. Furthermore, the shift toward personalized medicine is fueling demand for advanced imaging solutions that cater to individual patient needs. AI-driven algorithms can analyze vast datasets to provide tailored treatment options, improving patient outcomes and driving market growth in Europe.

The increasing prevalence of brain disorders in Europe, coupled with growing awareness of the importance of early diagnosis and intervention, is driving the demand for brain imaging devices. This demand is further accelerated by favorable reimbursement policies and government initiatives to improve access to advanced medical technologies. For instance, the Human Brain Project (HBP) was a collaborative effort spanning multiple European nations, aimed at advancing neuroscience and medicine and developing brain-inspired information technology.

The UK brain imaging devices marketis expected to grow due to technological advancements, which have led to the development of more precise and efficient imaging devices. Healthcare facilities are increasingly adopting these devices, and the country's growing research and development (R&D) activities are further expected to boost market growth.

The brain imaging devices market in Germanyis also expected to grow from 2026 to 2033. This can be attributed to the rapid aging of the population, which increases the prevalence of brain disorders such as Alzheimer's disease. In addition, the country’s well-developed healthcare system, highly skilled workforce, and substantial healthcare spending contribute to this growth.

Latin America Brain Imaging Devices Market Trends

The brain imaging devices market in Latin America is expected to experience moderate growth over the forecast period. This is owing to the growing awareness and recognition of the importance of early detection and diagnosis of brain-related conditions among healthcare professionals and the general population. This increased awareness is driving the demand for advanced diagnostic technologies, including brain imaging and monitoring devices, to help timely identify and treat such conditions.

Middle East & Africa Brain Imaging Devices Market Trends

The brain imaging devices market in MEA is anticipated to grow in the coming years. There is a rising prevalence of brain disorders across various countries in the MEA region. Factors such as aging populations, changing lifestyles, and increased awareness of mental health issues contribute to the increasing incidence of these conditions. As a result, there is a growing demand for early detection and treatment of brain disorders. Thus, boosting market growth.

Key Brain Imaging Devices Company Insights

Some of the key companies in the market include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, Medtronic, and Canon Inc.

  • Siemens Healthineers AG offers advanced medical technologies, including diagnostic imaging, laboratory diagnostics, and molecular medicine. The company provides solutions for healthcare providers to enhance patient care, improve efficiency, and drive innovation in medical treatments.

  • Medtronic provides a wide range of medical devices and therapies, including solutions for cardiovascular, diabetes, neurology, and surgical procedures. The company focuses on improving patient outcomes through innovative technologies and advanced healthcare solutions worldwide.

Key Brain Imaging Devices Companies

The following key companies have been profiled for this study on the brain imaging devices market:

  • GE Healthcare

  • Koninklijke Philips N.V.

  • Siemens Healthineers AG

  • Medtronic

  • Compumedics Limited

  • MEGIN

  • CTF MEG NEURO INNOVATIONS, INC.

  • FieldLine Inc

  • Cerca Magnetics Limited

  • Advanced Brain Monitoring, Inc.

  • Canon Inc.

  • Natus Medical Incorporated

  • Magstim

  • Cadwell Industries Inc.

  • Nihon Kohden Corporation

  • NeuroLogica Corp.

Recent Developments

  • In March 2025, Hyperfine announced a collaboration with NVIDIA to advance AI-powered neuroimaging by integrating accelerated computing and artificial intelligence into its portable MRI platform. The partnership aims to enhance brain image reconstruction, improve scan speed, and increase diagnostic accuracy, reinforcing the growing adoption of AI-enabled innovations in brain imaging devices to enable faster, more efficient neurological assessment.

  • In February 2025, MYndspan partnered with MEGIN to improve access to MEG brain scanning technology, aiming to expand the availability of high-precision functional brain imaging beyond traditional clinical settings. This development reflects the growing focus on accessible and advanced neuroimaging solutions for early neurological assessment.

  • In February 2024, Philips, in collaboration with Synthetic MR, launched Smart Quant Neuro 3D to diagnose and evaluate the effectiveness of therapy for brain disorders such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology offers automated measurement of various brain tissues, decision-making support for brain diseases, tracking of progression, and evaluation of therapy outcomes.

Brain Imaging Devices Market Report Scope

Report Attribute

Details

Market size in 2025

USD 6.1 billion

Estimated market size in 2026

USD 6.6 billion

Projected market size by 2033

USD 11.4 billion

Growth rate

CAGR of 8.2% from 2026 to 2033

Actual data

2021 - 2025

Forecast period

2026 - 2033

Quantitative units

Revenue in USD billion, and CAGR from 2026 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, modality, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

GE HealthCare; Koninklijke Philips N.V.; Siemens Healthineers AG; Medtronic; Compumedics Limited; MEGIN; CTF MEG NEURO INNOVATIONS, INC.; FieldLine Inc.; Cerca Magnetics Limited; Advanced Brain Monitoring, Inc.; Canon Inc.; Natus Medical Incorporated; Magstim; Cadwell Industries Inc.; Nihon Kohden Corporation; NeuroLogica Corp.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options

Global Brain Imaging Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global brain imaging devices market report based on product, application, modality, end-use, and region:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
    • Devices
      • EEG
      • MEG
      • MRI
      • CT
      • PET
      • Other Devices
    • Accessories
      • Electrodes
      • Sensors
      • Other Accessories
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
    • Stroke
    • Brain Tumor
    • Traumatic Brain Injury (TBI)
    • Epilepsy
    • Sleep Apnea
    • Headache
    • Structural Anomalies
    • Other Applications
  • Modality Outlook (Revenue, USD Billion, 2021 - 2033)
    • Fixed
    • Portable
    • Wearable
  • End-use Outlook (Revenue, USD Billion, 2021 - 2033)
    • Hospital
    • Diagnostic Imaging Centers
    • Ambulatory Surgery Centers
    • Other End Users
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Thailand
    • Latin America
      • Brazil
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Frequently Asked Questions About This Report

About the Author(s)

Medical Devices Research Team

Healthcare · Medical Devices

This report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo